OrbiMed, a US-based healthcare investment firm, has filed to raise up to $750 million for its fourth Asia-focused healthcare fund, nearly three years after it closed the predecessor fund, according to a US SEC document.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
